Imidazopyridine derivatives
US6403588B1 · kind B1 · utility
89Cited by
1References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 26, 2001 |
| Grant date | Jun 11, 2002 |
| Priority date | — |
| Expiry date | Apr 26, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds having a phosphatidylinositol 3 kinase (PI3K) inhibiting activity which are useful as medicaments, more particularly as antitumor agent. Novel 3-(imidazo[1,2-a]pyridin-3-yl) derivatives or salts thereof exhibit an excellent PI3K inhibiting activity and cancer cell growth inhibiting activity, and are thus useful as medicaments, especially as PI3K inhibitors and antitumor agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.